With increased urbanization and air travel, Southeast Asia has become a “hotspot” for emerging infectious diseases, experts say.
Is the biotech ecosystem in Singapore truly self-sustaining? A senior panel of speakers shared their views at the recent Oxbridge Biotech Roundtable session.
Takeda Pharma has submitted New Drug Applications for cell culture-based H5N1 influenza vaccines to the Ministry of Health, Labor and Welfare in Japan.
Indonesian health officials have downplayed concerns over a fresh outbreak of avian influenza which has killed some 160,000 reared ducks since September 2012.
Scientists have made a startling discovery that pigs in China's Guangdong province are infected with avian influenza viruses.
French biotech Fab'entech has launched a Phase I clinical trial in Singapore for its product against the H5N1 Avian Influenza virus.
Scientists in Singapore have developed a new H5N1 bird flu diagnostic kit that detects all known strains of the virus with a single test.
The world’s leading avian flu researchers have agreed to suspend avian flu transmission research for 60 days amid growing biosafety and biosecurity concerns.